Advertisement
Canada markets closed
  • S&P/TSX

    22,814.81
    +206.78 (+0.91%)
     
  • S&P 500

    5,459.10
    +59.88 (+1.11%)
     
  • DOW

    40,589.34
    +654.27 (+1.64%)
     
  • CAD/USD

    0.7229
    -0.0006 (-0.08%)
     
  • CRUDE OIL

    76.44
    -1.84 (-2.35%)
     
  • Bitcoin CAD

    95,749.59
    +1,831.97 (+1.95%)
     
  • CMC Crypto 200

    1,395.49
    +64.89 (+4.88%)
     
  • GOLD FUTURES

    2,385.70
    +32.20 (+1.37%)
     
  • RUSSELL 2000

    2,260.07
    +37.09 (+1.67%)
     
  • 10-Yr Bond

    4.2000
    -0.0560 (-1.32%)
     
  • NASDAQ

    17,357.88
    +176.16 (+1.03%)
     
  • VOLATILITY

    16.39
    -2.07 (-11.21%)
     
  • FTSE

    8,285.71
    +99.36 (+1.21%)
     
  • NIKKEI 225

    37,667.41
    -202.10 (-0.53%)
     
  • CAD/EUR

    0.6654
    -0.0013 (-0.19%)
     

Is This the Telltale Sign to Sell Novavax Stock?

Is This the Telltale Sign to Sell Novavax Stock?

Unfortunately, Novavax (NASDAQ: NVAX) hasn't had great timing. The company was late to the party in winning authorizations for its COVID-19 vaccine, Nuvaxovid. If you only looked at Novavax's press releases, you wouldn't know about some recent bad news for the company.